Gaelle Quereux

Gaelle Quereux

Clermont-ferrand, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 159 publications

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.

primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 16, 2026

PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy.

PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy.

Journal: Journal of translational medicine

Published: April 15, 2026

Real-World Use of Adjuvant Nivolumab for Resected Stage III-IV Melanoma: 2-Year Analysis of AdjuMel.

Real-World Use of Adjuvant Nivolumab for Resected Stage III-IV Melanoma: 2-Year Analysis of AdjuMel.

Journal: Dermatology and therapy

Published: March 20, 2026

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome.

Journal: The British journal of dermatology

Published: March 13, 2026

Comparison of an AI-based prognostic assay with gene expression profiling in early-stage melanoma.

Comparison of an AI-based prognostic assay with gene expression profiling in early-stage melanoma.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 05, 2026

Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial.

Combined methotrexate and short-term superpotent topical corticosteroids compared with prolonged superpotent topical corticosteroids alone in bullous pemphigoid: a multicentre, noninferiority randomised clinical trial.

Journal: The British journal of dermatology

Published: December 02, 2025

Efficacy and safety of anti-PD-1 plus lenvatinib in mucosal melanoma: a real-world series.

Efficacy and safety of anti-PD-1 plus lenvatinib in mucosal melanoma: a real-world series.

Journal: Annales de dermatologie et de venereologie

Published: October 23, 2025

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Real-world outcomes of immune checkpoint inhibitors in people with HIV and skin cancer: a multicentre study.

Journal: The oncologist

Published: October 15, 2025

Incidence and mortality of mucous membrane pemphigoid in France.

Incidence and mortality of mucous membrane pemphigoid in France.

Journal: The British journal of dermatology

Published: September 28, 2025

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.

Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.

Journal: Nature medicine

Published: September 12, 2025

Showing 1-12 of 159

Last Updated: 09/26/2026